Prostate cancer treatment guidelines recommend against aggressive therapy for those with a life expectancy of less than 10 years.

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments ...

Growing evidence indicates that more patients with favorable Grade Group 2 prostate cancer can be successfully managed with active surveillance and achieve acceptable oncologic outcomes, even if later ...

This trend runs counter to efforts promoting “active surveillance” of prostate cancers in men where treatment would ...

At the same time, aggressive treatment declined in men with low-risk prostate cancer as might have been expected in an era ...

In a study of US veterans, the authors say many would benefit from conservative management and active surveillance over ...

Hormone therapy initiation depends on disease extent; some agents avoid testosterone flare, allowing ADT without Casodex in ...

During active surveillance, biopsies are performed at regular intervals in order to look for change in the prostate cancer that would move it to a higher grade group. This is called grade ...

(HealthDay News) — In the active surveillance era, overtreatment of men with limited life expectancy (LE) decreased for those ...

A precursor of vitamin K may help slow down prostate cancer progression, a recent study conducted in mouse models of suggests ...

A recent study led by Cedars-Sinai researchers reveals that a growing number of older men in the U.S. with intermediate or ...

Clinicians must appropriately assess life expectancy and take steps to avoid prostate cancer overtreatment. Even in the active surveillance era, overtreatment persists among men with limited life ...